- Home
- LESL vs PROK Comparison
LESL vs PROK Comparison
Compare LESL & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- PROK
- Stock Information
- Founded
- LESL 1963
- PROK 2015
- Country
- LESL United States
- PROK United States
- Employees
- LESL N/A
- PROK N/A
- Industry
- LESL Diversified Commercial Services
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LESL Miscellaneous
- PROK Health Care
- Exchange
- LESL Nasdaq
- PROK Nasdaq
- Market Cap
- LESL 156.0M
- PROK 126.8M
- IPO Year
- LESL 2020
- PROK N/A
- Fundamental
- Price
- LESL $0.83
- PROK $0.91
- Analyst Decision
- LESL Hold
- PROK Buy
- Analyst Count
- LESL 11
- PROK 4
- Target Price
- LESL $2.70
- PROK $5.00
- AVG Volume (30 Days)
- LESL 5.9M
- PROK 551.9K
- Earning Date
- LESL 05-07-2025
- PROK 03-17-2025
- Dividend Yield
- LESL N/A
- PROK N/A
- EPS Growth
- LESL N/A
- PROK N/A
- EPS
- LESL N/A
- PROK N/A
- Revenue
- LESL $1,331,389,000.00
- PROK $76,000.00
- Revenue This Year
- LESL $2.85
- PROK N/A
- Revenue Next Year
- LESL $3.00
- PROK N/A
- P/E Ratio
- LESL N/A
- PROK N/A
- Revenue Growth
- LESL N/A
- PROK N/A
- 52 Week Low
- LESL $0.75
- PROK $0.87
- 52 Week High
- LESL $6.64
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- LESL 33.55
- PROK 32.38
- Support Level
- LESL $0.75
- PROK $0.87
- Resistance Level
- LESL $0.96
- PROK $1.06
- Average True Range (ATR)
- LESL 0.09
- PROK 0.10
- MACD
- LESL 0.04
- PROK 0.01
- Stochastic Oscillator
- LESL 32.39
- PROK 21.95
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.